Treatment failure may lead to accelerated fibrosis progression in patients with chronic hepatitis C.


Chronic hepatitis C (CHC) patients with treatment failure (TF) remain at risk of continuing fibrosis progression. However, it has not been investigated whether there is an increased risk of accelerated fibrosis progression after failed interferon-based therapy. We aimed to investigate long-term influence of TF on fibrosis progression compared with untreated… (More)
DOI: 10.1111/jvh.12127


  • Blog articles referencing this paper

  • Presentations referencing similar topics